Researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) conducted a study using the NK-92 cell line to test new...

A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute, USA, has shown that a single injection of an oncolytic virus—a...

A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute, USA, has shown that a single injection of an oncolytic virus—a...

Dr Bruce Levine of the University of Pennsylvania will receive the Genome Valley Excellence Award 2026 at BioAsia for his groundbreaking work in cell...

Leading Australian blood cancer researchers have delivered a breakthrough treatment that significantly improves survival and quality of life for young...

Leading Australian blood cancer researchers have delivered a breakthrough treatment that significantly improves survival and quality of life for young...

Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from...

Eli Lilly is set to buy Orna Therapeutics for $2.4B to expand in vivo CAR-T and circular RNA capabilities, signaling a long-term push to diversify its...

Immunotherapy – which activates the body's own immune system to kill cancer cells – has not worked well against a rare and fatal liver cancer, but...

Cell and gene therapies, or CGT, have come a long way since they were first introduced. In the last few decades, both cell therapy -- the...